S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
DaVita Inc. stock logo
DVA
DaVita
$129.96
-0.4%
$129.34
$71.51
$141.54
$11.40B1.04833,365 shs449,306 shs
HemaCare Co. stock logo
HEMA
HemaCare
$25.31
+0.6%
$25.31
$8.62
$26.23
$346.52M1.4739,950 shs5,400 shs
Progyny, Inc. stock logo
PGNY
Progyny
$33.81
-1.1%
$37.28
$29.44
$44.95
$3.30B1.48783,196 shs627,213 shs
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$32.50
$32.50
$21.25
$32.89
$1.62B2.14820,051 shs1,170 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
DaVita Inc. stock logo
DVA
DaVita
-0.35%-2.80%-4.90%+23.98%+54.79%
HemaCare Co. stock logo
HEMA
HemaCare
0.00%0.00%0.00%0.00%0.00%
Progyny, Inc. stock logo
PGNY
Progyny
-1.14%-5.66%-3.87%-11.82%+4.38%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
3.353 of 5 stars
1.22.00.04.52.02.52.5
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
4.3349 of 5 stars
4.51.00.00.02.93.33.1
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
2.33
Hold$118.50-8.82% Downside
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
3.00
Buy$48.3042.86% Upside
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/A

Current Analyst Ratings

Latest DVA, PGNY, TVTY, ARA, and HEMA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2024
DaVita Inc. stock logo
DVA
DaVita
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$133.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$48.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$47.00 ➝ $46.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$45.00 ➝ $43.00
2/26/2024
Progyny, Inc. stock logo
PGNY
Progyny
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Progyny, Inc. stock logo
PGNY
Progyny
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$49.00
2/20/2024
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$130.00 ➝ $135.00
2/14/2024
DaVita Inc. stock logo
DVA
DaVita
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$113.00 ➝ $134.00
2/14/2024
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$120.00 ➝ $130.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
DaVita Inc. stock logo
DVA
DaVita
$12.14B0.94$16.75 per share7.76$13.63 per share9.53
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$1.09B3.00$0.66 per share50.96$5.77 per share5.86
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$481.25M3.37$1.95 per share16.70$2.39 per share13.60

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
DaVita Inc. stock logo
DVA
DaVita
$691.53M$7.4017.5612.981.165.70%64.42%4.63%5/13/2024 (Estimated)
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/A0.00N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.6254.5334.861.415.70%12.64%8.82%5/13/2024 (Estimated)
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$104.91M$1.7119.0116.411.8217.25%75.94%13.65%N/A

Latest DVA, PGNY, TVTY, ARA, and HEMA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/27/2024Q4 2023
Progyny, Inc. stock logo
PGNY
Progyny
$0.09$0.13+$0.04$0.13$274.08 million$269.94 million      
2/13/2024Q4 23
DaVita Inc. stock logo
DVA
DaVita
$1.53$1.87+$0.34$2.12$3.01 billion$3.15 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
DaVita Inc. stock logo
DVA
DaVita
6.65
1.19
1.13
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/A
3.44
3.44
Tivity Health, Inc. stock logo
TVTY
Tivity Health
2.97
2.47
2.47

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
DaVita Inc. stock logo
DVA
DaVita
90.12%
HemaCare Co. stock logo
HEMA
HemaCare
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
91.54%

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
DaVita Inc. stock logo
DVA
DaVita
1.40%
HemaCare Co. stock logo
HEMA
HemaCare
26.20%
Progyny, Inc. stock logo
PGNY
Progyny
14.30%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
2.03%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
DaVita Inc. stock logo
DVA
DaVita
70,00087.70 million86.47 millionOptionable
HemaCare Co. stock logo
HEMA
HemaCare
N/A13.69 millionN/ANot Optionable
Progyny, Inc. stock logo
PGNY
Progyny
56396.50 million82.99 millionOptionable
Tivity Health, Inc. stock logo
TVTY
Tivity Health
38049.93 million48.92 millionOptionable

DVA, PGNY, TVTY, ARA, and HEMA Headlines

SourceHeadline
10 Foods for Thyroid Health—And 3 To Avoid10 Foods for Thyroid Health—And 3 To Avoid
health.com - March 12 at 8:18 AM
Tivity Health Appoints Hill Ferguson as President and CEOTivity Health Appoints Hill Ferguson as President and CEO
finance.yahoo.com - July 6 at 3:27 PM
Franklin-based health care company names new CEOFranklin-based health care company names new CEO
bizjournals.com - July 6 at 3:27 PM
Tivity CEO moves to Amedisys top spotTivity CEO moves to Amedisys top spot
nashvillepost.com - March 14 at 10:29 AM
TVTY.OTVTY.O
reuters.com - February 24 at 5:56 PM
Tivity Health acquires Pikesville’s Burnalong in a ‘growth investment’Tivity Health acquires Pikesville’s Burnalong in a ‘growth investment’
technical.ly - February 16 at 11:45 PM
Tivity Health buys digital health and wellness platform BurnalongTivity Health buys digital health and wellness platform Burnalong
bizjournals.com - February 1 at 3:16 PM
Tivity Health Acquires Industry Leading Digital Health and Wellness Platform BurnalongTivity Health Acquires Industry Leading Digital Health and Wellness Platform Burnalong
finance.yahoo.com - January 31 at 8:46 AM
Tivity Health has tips to prevent falls with Silver SneakersTivity Health has tips to prevent falls with Silver Sneakers
news.yahoo.com - October 11 at 7:10 PM
TVTY.OQTVTY.OQ
reuters.com - September 28 at 8:51 PM
WholeHealth Living to Partner with Vori Health to Provide Industry Leading Musculoskeletal SolutionWholeHealth Living to Partner with Vori Health to Provide Industry Leading Musculoskeletal Solution
finance.yahoo.com - September 6 at 6:32 PM
SilverSneakers Announces 2022 Member of the YearSilverSneakers Announces 2022 Member of the Year
stockhouse.com - August 16 at 8:51 PM
CEO Richard Ashworth on $2B Tivity Health sale: Were not keeping things status quoCEO Richard Ashworth on $2B Tivity Health sale: We're not 'keeping things status quo'
bizjournals.com - August 16 at 10:50 AM
Tivity Health CEO to be paid more than $30 million following deal to go privateTivity Health CEO to be paid more than $30 million following deal to go private
finance.yahoo.com - July 6 at 6:04 PM
Stone Point Capital closes $2 billion deal to purchase Tivity HealthStone Point Capital closes $2 billion deal to purchase Tivity Health
finance.yahoo.com - June 29 at 6:47 PM
Stone Point completes take-private buyout of Tivity Health for $32.50 per shareStone Point completes take-private buyout of Tivity Health for $32.50 per share
pehub.com - June 28 at 11:24 AM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates FHLT, TVTY, MN, ETTXINVESTIGATION ALERT: Halper Sadeh LLP Investigates FHLT, TVTY, MN, ETTX
apnews.com - June 15 at 12:25 PM
SilverSneakers Opens Nominations for Annual...SilverSneakers Opens Nominations for Annual...
benzinga.com - June 14 at 9:23 PM
Oversold Conditions For Tivity Health (TVTY)Oversold Conditions For Tivity Health (TVTY)
nasdaq.com - June 14 at 9:23 PM
SilverSneakers Opens Nominations for Annual Member of the Year AwardsSilverSneakers Opens Nominations for Annual Member of the Year Awards
finance.yahoo.com - June 13 at 3:19 PM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates TVTY, CMAX, GIACINVESTIGATION ALERT: Halper Sadeh LLP Investigates TVTY, CMAX, GIAC
markets.businessinsider.com - June 10 at 7:46 AM
SHAREHOLDER ALERT: Weiss Law Reminds ETTX, TVTY, MANT, and RTLRSHAREHOLDER ALERT: Weiss Law Reminds ETTX, TVTY, MANT, and RTLR
marketwatch.com - June 9 at 6:16 AM
SHAREHOLDER UPDATE: Halper Sadeh LLP Investigates CMAX, TVTY, GTYH, NTUSSHAREHOLDER UPDATE: Halper Sadeh LLP Investigates CMAX, TVTY, GTYH, NTUS
marketwatch.com - June 4 at 5:29 AM
Short Volatility Alert: Tivity Health, Inc.Short Volatility Alert: Tivity Health, Inc.
markets.businessinsider.com - June 1 at 3:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Renal Associates logo

American Renal Associates

NYSE:ARA
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.
DaVita logo

DaVita

NYSE:DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
HemaCare logo

HemaCare

OTCMKTS:HEMA
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.
Progyny logo

Progyny

NASDAQ:PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Tivity Health logo

Tivity Health

NASDAQ:TVTY
Tivity Health, Inc. provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was incorporated in 1981 and is headquartered in Franklin, Tennessee.